av/clinuvel-pharmaceuticals--big.svg

COM:CLINUVEL

CLINUVEL

  • Stock

Last Close

13.58

08/11 05:10

Market Cap

754.17M

Beta: -

Volume Today

54.82K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
418.57K
-
959.65K
129.27%
1.16M
21.07%
941.45K
18.97%
1.39M
47.51%
1.71M
23.28%
2.24M
30.68%
2.51M
12.16%
5.68M
126.19%
10.07M
77.48%
average payables
181.23K
-
219.53K
21.13%
245.81K
11.97%
405.24K
64.86%
504.01K
24.37%
964.39K
91.34%
1.47M
51.91%
1.88M
28.10%
1.29M
31.19%
1.53M
18.12%
2.57M
68.38%
average receivables
1.66M
-
1.77M
6.54%
3.39M
91.33%
4.03M
18.85%
4.16M
3.31%
4.62M
11.01%
5.38M
16.46%
11.35M
110.80%
16.15M
42.24%
19.21M
18.97%
24.23M
26.13%
book value per share
0.40
-
0.26
35.20%
0.39
52.11%
0.53
35.52%
0.83
55.03%
1.19
43.72%
1.50
26.04%
2.00
33.62%
2.54
27.16%
3.33
31.12%
4.05
21.55%
capex per share
-0.00
-
-0.00
214.11%
-0.00
676.31%
-0.00
34.62%
-0.00
11.16%
-0.01
239.74%
-0.02
237.53%
-0.02
4.17%
-0.01
49.15%
-0.02
136.52%
0.11
634.92%
capex to depreciation
-0.09
-
-0.46
397.10%
-3.84
742.71%
-1.27
66.94%
-1.69
32.81%
-0.57
-
4.88
-
capex to operating cash flow
0.00
-
0.00
273.74%
0.02
628.93%
-0.01
134.95%
-0.01
-
-0.06
348.80%
-0.04
29.20%
-0.02
54.73%
-0.03
38.64%
0.15
640.60%
capex to revenue
-0.00
-
-0.00
166.04%
-0.02
279.94%
-0.00
74.43%
-0.00
26.96%
-0.01
181.49%
-0.03
228.94%
-0.02
34.76%
-0.01
62.88%
-0.01
98.47%
0.06
582.02%
cash per share
0.38
-
0.24
35.51%
0.31
25.42%
0.50
62.98%
0.76
52.17%
1.13
48.53%
1.35
20.32%
1.67
23.51%
2.46
46.94%
3.17
29.05%
6.63
109.03%
days of inventory on hand
117.39
-
105.76
9.91%
111.82
5.73%
39.11
65.03%
113.47
190.14%
48.82
56.98%
246.41
404.78%
63.78
74.12%
395.31
519.82%
384.74
2.67%
days payables outstanding
19.99
-
36.54
82.78%
22.58
38.22%
52.19
131.14%
26.13
49.92%
79.69
204.92%
54.20
31.99%
179.67
231.52%
9.02
94.98%
115.93
1,184.65%
84.92
26.75%
days sales outstanding
263.02
-
245.77
6.56%
283.46
15.34%
70.71
75.05%
72.90
3.10%
48.86
32.98%
74.12
51.69%
122.40
65.15%
89.98
26.49%
103.53
15.05%
108.61
4.91%
debt to assets
0.01
-
0.02
133.26%
0.01
25.81%
0.01
27.30%
0.01
40.87%
0.00
26.25%
debt to equity
0.01
-
0.02
136.80%
0.01
26.30%
0.01
24.19%
0.01
39.31%
0.00
28.64%
dividend yield
0.00
-
0.00
60.95%
0.00
15.94%
0.00
106.73%
0.00
32.89%
0.00
44.26%
earnings yield
-0.08
-
-0.08
0.65%
-0.02
80.93%
0.02
233.88%
0.03
16.57%
0.01
54.67%
0.01
15.54%
0.02
23.73%
0.03
74.55%
0.03
21.74%
0.05
34.39%
enterprise value
51.16M
-
112.61M
120.11%
181.79M
61.44%
308.99M
69.97%
489.45M
58.41%
1.54B
213.91%
1.20B
22.02%
1.44B
19.82%
613.49M
57.26%
727.64M
18.61%
582.45M
19.95%
enterprise value over ebitda
-8.13
-
-10.02
23.31%
-43.71
336.07%
45.75
204.66%
40.14
12.25%
83.73
108.57%
88.16
5.29%
50.92
42.24%
16.42
67.74%
14.68
10.61%
10.35
29.50%
ev to operating cash flow
-10.64
-
-24.86
133.66%
-36.09
45.18%
31.16
186.33%
83.25
-
84.44
1.43%
74.53
11.74%
28.35
61.95%
19.71
30.48%
15.72
20.26%
ev to sales
23.25
-
38.68
66.33%
29.27
24.33%
18.48
36.86%
19.20
3.92%
49.49
157.67%
36.79
25.66%
29.92
18.67%
9.33
68.80%
9.29
0.47%
6.61
28.90%
free cash flow per share
-0.12
-
-0.10
15.79%
-0.11
8.28%
0.21
282.22%
-0.00
100.76%
0.38
24,100.08%
0.27
28.51%
0.37
37.99%
0.43
15.18%
0.73
69.25%
0.63
13.54%
free cash flow yield
-0.07
-
-0.04
49.59%
-0.03
28.81%
0.03
212.78%
-0.00
100.48%
0.01
8,107.30%
0.01
8.02%
0.01
15.29%
0.03
138.11%
0.04
40.57%
0.04
1.24%
graham net net
0.36
-
0.23
36.53%
0.35
50.03%
0.50
43.04%
0.77
55.64%
1.11
43.27%
1.31
18.37%
1.75
33.78%
2.35
34.29%
3.02
28.37%
6.57
117.70%
graham number
1.13
-
1.18
4.38%
0.78
33.58%
1.34
71.21%
2.27
68.84%
3.17
39.73%
3.37
6.39%
4.74
40.67%
4.92
3.62%
6.81
38.64%
8.05
18.11%
income quality
0.87
-
0.43
50.02%
1.60
267.19%
1.38
13.53%
1.04
-
1.04
-
intangibles to total assets
0
-
0
0
0
0.00
Infinity%
0.00
31.18%
0.00
23.54%
0.00
24.89%
0.00
24.58%
0.00
25.69%
0.00
16.19%
interest coverage
858.95
-
508.47
40.80%
16.89
96.68%
16.09
4.72%
15.28
5.06%
12.38
18.97%
interest debt per share
0.01
-
0.03
190.15%
0.06
116.51%
0.07
20.84%
0.08
18.74%
0.11
25.41%
inventory turnover
3.11
-
3.45
11.00%
3.26
5.42%
9.33
185.92%
3.22
65.53%
7.48
132.44%
1.48
80.19%
5.72
286.35%
0.92
83.87%
0.95
2.75%
invested capital
0.01
-
0.02
136.80%
0.01
26.30%
0.01
24.19%
0.01
39.31%
204.76M
3,371,389,739,617.10%
market cap
65.79M
-
123.18M
87.25%
195.64M
58.82%
332.74M
70.08%
525.65M
57.98%
1.59B
202.54%
1.26B
20.55%
1.52B
20.05%
733.74M
51.63%
883.46M
20.40%
765.44M
13.36%
net current asset value
15.31M
-
11.14M
27.28%
17.67M
58.67%
25.31M
43.22%
38.78M
53.24%
55.99M
44.37%
67.28M
20.18%
93.02M
38.25%
122.19M
31.36%
160.54M
31.38%
193.95M
20.82%
net debt to ebitda
2.32
-
0.94
59.51%
3.33
253.72%
-3.52
205.64%
-2.97
15.58%
-2.93
1.18%
-4.81
64.10%
-2.89
40.04%
-3.22
11.52%
-3.14
2.34%
-3.25
3.43%
net income per share
-0.14
-
-0.24
68.15%
-0.07
71.00%
0.15
316.31%
0.28
83.88%
0.38
35.86%
0.34
10.20%
0.50
48.09%
0.42
15.57%
0.62
46.58%
0.71
14.78%
operating cash flow per share
-0.12
-
-0.10
15.96%
-0.11
6.50%
0.21
287.04%
0.38
-
0.29
24.79%
0.39
35.35%
0.44
12.33%
0.75
70.60%
0.74
1.05%
payables turnover
18.26
-
9.99
45.29%
16.17
61.86%
6.99
56.74%
13.97
99.68%
4.58
67.20%
6.73
47.04%
2.03
69.84%
40.45
1,890.99%
3.15
92.22%
4.30
36.52%
receivables turnover
1.39
-
1.49
7.02%
1.29
13.30%
5.16
300.88%
5.01
3.01%
7.47
49.20%
4.92
34.08%
2.98
39.45%
4.06
36.03%
3.53
13.08%
3.36
4.68%
research and ddevelopement to revenue
0.03
-
return on tangible assets
-0.32
-
-0.76
136.95%
-0.16
79.48%
0.25
260.29%
0.31
23.32%
0.29
5.76%
0.20
29.86%
0.23
11.51%
0.15
36.35%
0.16
8.89%
0.15
2.42%
revenue per share
0.06
-
0.07
18.07%
0.14
104.32%
0.35
155.73%
0.53
52.19%
0.64
20.69%
0.66
2.61%
0.97
46.87%
1.33
36.99%
1.59
19.17%
1.76
10.98%
roe
-0.36
-
-0.93
159.48%
-0.18
80.93%
0.28
259.62%
0.34
18.61%
0.32
5.47%
0.23
28.75%
0.25
10.83%
0.17
33.60%
0.19
11.80%
0.18
5.57%
roic
-0.38
-
-0.97
152.72%
-0.22
77.53%
0.28
227.80%
0.31
13.19%
0.31
0.67%
0.22
30.12%
0.26
18.65%
0.17
32.98%
0.20
13.06%
0.19
3.25%
sales general and administrative to revenue
2.06
-
3.61
74.84%
0.90
75.06%
0.29
67.56%
0.26
10.16%
0.27
-
0.27
1.32%
0.29
6.92%
0.28
1.50%
shareholders equity per share
0.40
-
0.26
35.20%
0.39
52.11%
0.53
35.52%
0.83
55.03%
1.19
43.72%
1.50
26.04%
2.00
33.62%
2.54
27.16%
3.33
31.12%
4.05
21.55%
stock based compensation to revenue
tangible asset value
15.43M
-
11.21M
27.37%
17.83M
59.16%
25.44M
42.67%
39.23M
54.19%
56.99M
45.28%
73.48M
28.93%
98.55M
34.11%
125.37M
27.22%
164.45M
31.16%
202.83M
23.34%
tangible book value per share
0.40
-
0.26
35.20%
0.39
52.44%
0.53
35.53%
0.82
53.95%
1.18
43.93%
1.49
26.13%
1.99
33.71%
2.54
27.22%
3.33
31.16%
4.05
21.58%
working capital
15.32M
-
11.14M
27.29%
17.69M
58.77%
25.32M
43.18%
38.80M
53.22%
56.19M
44.83%
68.50M
21.89%
94.14M
37.44%
126.85M
34.74%
164.12M
29.38%
196.85M
19.94%

All numbers in (except ratios and percentages)